Glycaemia is associated with cognitive impairment in older adults: The Guangzhou Biobank Cohort Study

Age and Ageing

Volumn 44, Issue 1, 2015, Pages 65-71

  Jagielski, A C ^a,b   Jiang, C Q ^c   Xu, L ^d   Taheri, S ^b,e,f,g   Zhang, W S ^c   Cheng, K K ^a   Lam, T H ^d   Thomas, G N ^a,h  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b Birmingham and Black Country NIHR CLAHRC   (United Kingdom)

^c Guangzhou Number 12 People's Hospital   (China)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^g KING'S COLLEGE LONDON   (United Kingdom)

^h MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

Author keywords

Cognition; Glycaemia; Older adult; Type 2 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

ADULT; AGE; ARTICLE; BODY MASS; CHINESE; COGNITIVE DEFECT; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DELAYED WORD RECALL TEST; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FASTING; FASTING BLOOD GLUCOSE LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEMORY TEST; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; ODDS RATIO; RISK ASSESSMENT; SOCIAL STATUS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; AGED; AGING; ANALYSIS; ANALYSIS OF VARIANCE; BLOOD; CHINA; COGNITION; COGNITION DISORDERS; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIET RESTRICTION; HEALTH CARE FACILITY; NEUROPSYCHOLOGICAL TEST; PREDICTIVE VALUE; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; RISK; RISK FACTOR; STATISTICAL MODEL; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BIOLOGICAL SPECIMEN BANKS; BLOOD GLUCOSE; CHINA; COGNITION; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; RISK ASSESSMENT; RISK FACTORS;

EID: 84930918835     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/AGEING/AFU088     Document Type: Article

References (30)

1. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006; 5: 64-74.
2. Croxson SC, Jagger C. Diabetes and cognitive impairment: a community-based study of elderly subjects. Age Ageing 1995; 24: 421-4.
3. Elias PK, Elias MF, D'Agostino RB et al. NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study. Diabetes Care 1997; 20: 1388-95.
4. Chau PH, Woo J, Lee CH et al. Older people with diabetes have higher risk of depression, cognitive and functional impairments: implications for diabetes services. J Nutr Health Aging 2011; 15: 751-5.
5. Ohara T, Doi Y, Ninomiya T et al. Glucose tolerance status and risk of dementia in the community: the Hisayama study. Neurology 2011; 20: 1126-34.
6. Robertson-Tchabo EA, Arenberg D, Tobin JD, Plotz JB. A longitudinal study of cognitive performance in noninsulin dependent (type II) diabetic men. Exp Gerontol 1986; 21: 459-67.
7. Saczynski JS, Jonsdottir MK, Garcia ME et al. Cognitive impairment: an increasingly important complication of type 2 diabetes: the age, gene/environment susceptibility - Reykjavik study. Am J Epidemiol 2008; 168: 1132-9.
8. Thomas GN, Jiang CQ, Lao XQ et al. Snoring and vascular risk factors and disease in a low-risk Chinese population: the Guangzhou Biobank Cohort Study. Sleep 2006; 29: 896-900.
9. Welsh KA, Butters N, Mohs RC et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology 1994; 44: 609-14.
10. Heys M, Jiang C, Cheng KK et al. Life long endogenous estrogen exposure and later adulthood cognitive function in a population of naturally postmenopausal women from Southern China: the Guangzhou Biobank Cohort Study. Psychoneuroendocrinology 2011; 36: 864-73.
11. Heys M, Jiang C, Cheng KK et al. Does the age of achieving pubertal landmarks predict cognition in older men? Guangzhou Biobank Cohort Study. Ann Epidemiol 2010; 20: 948-54.
12. Au Yeung SL, Jiang CQ, Cheng KK et al. Evaluation of moderate alcohol use and cognitive function among men using a Mendelian randomization design in the Guangzhou Biobank Cohort Study. Am J Epidemiol 2012; 175: 1021-8.
13. Lezak MD, Howieson DB, Loring DW. Neuropsychological Assessment, 4th edition. Oxford: Oxford University Press, 2004.
14. Crosby-Nwaobi R, Sivaprasad S, Forbes A. A systematic review of the association of diabetic retinopathy and cognitive impairment in people with Type 2 diabetes. Diabetes Res Clin Pract 2012; 96: 101-10.
15. Yaffe K, Blackwell T, Kanaya AM et al. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 2004; 63: 658-63.
16. Strachan MW, Deary IJ, Ewing FM, Frier BM. Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 1997; 20: 438-45.
17. Marioni RE, Strachan MW, Reynolds RM et al. Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabetes 2010; 59: 710-3.
18. Thomas GN, Chen XY, Lin JW et al. Middle cerebral artery stenosis increased the risk of vascular disease mortality among type 2 diabetic patients. Cerebrovasc Dis 2008; 25: 261-7.
19. Hachinski V. Shifts in thinking about dementia. JAMA 2008; 300: 2172-3.
20. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12 year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-44.
21. Kothari V, Stevens RJ, Adler AI et al. UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke 2002; 33: 1776-81.
22. Sander D, Sander K, Poppert H. Stroke in type 2 diabetes. Br J Diabetes Vasc Dis 2008; 8: 222-9.
23. Luchsinger JA, Tang MX, Stern Y, Shea S, Mayeux R. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 2001; 154: 635-741.
24. Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes 2008; 26: 77-82.
25. Friedlander AH, Garrett NR, Norman DC. The prevalence of calcified carotid artery atheromas on the panoramic radio-graphs of patients with type 2 diabetes mellitus. J Am Dent Assoc 2002; 133: 1516-23.
26. Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia 2001; 44: 129-46.
27. Valente T, Gella A, Fernandez-Busquets X, Unzeta M, Durany N. Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus. Neurobiol Dis 2010; 37: 67-76.
28. Yaffe K, Lindquist K, Schwartz AV et al. Advanced glycation end product level, diabetes, and accelerated cognitive aging. Neurology 2011; 77: 1351-6.
29. van Harten B, Oosterman J, Muslimovic D, van Loon BJ, Scheltens P, Weinstein HC. Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus. Age Ageing 2007; 36: 164-70.
30. Gu D, Reynolds K, Duan X et al. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia 2003; 46: 1190-8.